Esteatosis hepática focal multinodular. Presentación de una paciente
Texto completo:
PDFResumen
Palabras clave
Referencias
Turkish AR. Nonalcoholic fatty liver disease: emerging mechanisms and consequences. Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):128-33.
Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus. Endocr Res. 2007;32(3):59-69.
Musso G, Gambino R, Cassader M. A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease. Hepatology. 2010;52:79-104. doi: 10.1002/hep.23623.
Córdova Pluma VH. Hígado graso no alcohólico: un encuadre didáctico para un problema latente. Segunda parte. Med Int Mex. 2009;25(2):129-53.
Vanni E, Bugianesi E, Kotronen A. From the metabolic to NAFLD o vice versa? Dig Liver Dis 2010;42:320-30.
Feldstedin AE, Wieckowska A, López A. Cytokeratins -18 fragment for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2013;50:1072-78.
Chavez-Tapia NC, Uribe M, Ponciano-Rodriguez G, Medina-Satillan R, Mendez-Sanchez N. New Insights into the pathophysiology of non-alcoholic fatty liver. Ann Hepatol. 2009;8(1):S9-S17.
Tilg H, Moschen A. Evolution of inflammation in Non alcoholic Fatty Liver Disease: The multiple Parallel Hits Hypothesis. Hepatology. 2010;52:1836-46.
Estep JM, Bererdinc A, Younossi Z. Non-Invasive Diagnosatic Test forNon-Alcoholic Fatty Liver Disease 2010. Cur Mol Med. 2010;10:166-72.
Ratziu V, Bellenteni S, Cortez-Pinto DC, Marchesini G. A position statement on NAFLD|NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372-84.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2016 Maryla Martínez-Fortún Amador, Ana Dorsy Cabrera Barreto, María Cristina Pozo del Sol